Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academy

Autor: Elaine Julian, Mira Pavlovic, Oriol Sola-Morales, Fabrizio Gianfrate, Mondher Toumi, Heiner C. Bucher, Christian Dierks, Wolfgang Greiner, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Antonella Cardone, Jörg Ruof

Publikováno v: Health Economics Review, Vol 12, Iss 1, Pp 1-15 (2022)

Abstract Objectives Key challenges for a joint European Health Technology Assessment (HTA) include consolidated approaches towards the choice of adequate comparator(s), selection of endpoints that are relevant to patients with a given disease, dealin

Externí odkaz: https://doaj.org/article/49b7e3fc8c3140c6be0c21e052b00350

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

Autor: Giovanni Giuliani, Frederic Chassagnol, David Traub, Marlene Gyldmark, Ansgar Hebborn, Pierre Ducournau, Jörg Ruof

Publikováno v: Health Economics Review, Vol 8, Iss 1, Pp 1-11 (2018)

Abstract Background Health Technology Assessments (HTA) procedures differ substantially across the various European countries. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany) and

Externí odkaz: https://doaj.org/article/3954396c651349efa31857e995d62dc8

Is the EUNETHTA HTA CORE MODEL® fit for Purspose? Evaluation from an Industry Perspective

Autor: Ansgar Hebborn, Marlene Gyldmark, Kristian Lampe, Jörg Ruof, Johannes Pöhlmann, Finn Børlum Kristensen

Publikováno v: Gyldmark, M, Lampe, K, Ruof, J, Pöhlmann, J, Hebborn, A & Kristensen, F B 2018, ' Is the EUNETHTA HTA CORE MODEL® fit for Purspose? Evaluation from an Industry Perspective ', International Journal of Technology Assessment in Health Care, vol. 34, no. 5, pp. 458-463 . https://doi.org/10.1017/S0266462318000594

Objectives:The HTA Core Model® was developed to improve the transferability of health technology assessment (HTA) between settings. The model has been used by HTA agencies but is also of interest to manufacturers, for improving internal evidence gen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0ba51c819b4218d38407e2ef9c04be
https://findresearcher.sdu.dk:8443/ws/files/145603697/is_the_eunethta_hta_core_model_fit_for_purpose_evaluation_from_an_industry_perspective.pdf

Systematic overview of cost–effectiveness thresholds in ten countries across four continents

Autor: Beate Jahn, Martina Lackner, Karl Pugner, Ansgar Hebborn, Petra Schnell-Inderst, Gaby Sroczynski, Andras Fehervary, Imke Schall, Ruth Schwarzer, Bernhard Bornschein, Uwe Siebert, Nikolai Muehlberger, Ursula Rochau, K.R. Saverno, Diana I. Brixner, Magdalena Flatscher-Thoeni

Publikováno v: Journal of Comparative Effectiveness Research. 4:485-504

Aim: To provide an overview of thresholds for incremental cost–effectiveness ratios (ICERs) representing willingness-to-pay (WTP) across multiple countries and insights into exemptions pertaining to the ICER (e.g., cancer). To compare ICER threshol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5afddf76589b73e334e7bdac55a02499
https://doi.org/10.2217/cer.15.38

Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom

Autor: Andrew J.S. Coats, Simon Stewart, John J.V. McMurray, Ansgar Hebborn, Milton Packer

Publikováno v: International Journal of Cardiology. 100:143-149

Background The aim of this study was to determine the effects of carvedilol on the costs related to the treatment of severe chronic heart failure (CHF). Methods Costs for the treatment for heart failure within the National Health Service (NHS) in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4463eb5d962a38e2c00ac6841f6c0c52
https://doi.org/10.1016/j.ijcard.2004.12.003